Abstract
Purpose: This study was designed to determine the incidence of venous and arterial thromboembolic events (TEEs) in patients with bladder cancer treated with neoadjuvant cisplatin-based chemotherapy and to analyse the prognostic baseline and treatment characteristics using Khorana and adapted HADVAS score in predicting TEE occurrences.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
